by PEAK Medicals | 13 December 2023
Breast Cancer 2023 Review Welcome & introduction by host Peter Dubsky Early breast cancer and local therapies Peter Dubsky Latest advances with antibody-drug conjugates and immunotherapies Nadia Harbeck Highlights of 2023 in endocrine and combination therapies Khalil...
by PEAK Medicals | 1 November 2023
ADC in Breast, GU & Lung Welcome & introduction by host Alfredo Addeo New ADCs in Breast Cancer Paolo Tarantino An Update on ADCs in GU Shilpa Gupta Novel ADCs in Lung Cancer Treatment Alfredo Addeo  } 1 h 31 min Get Your CME...
by PEAK Medicals | 28 June 2023
Breast Cancer (ASCO 2023) Welcome & introduction by host Nadia Harbeck How do the latest ASCO-data integrate into the treatment of HR+ / HER- adv. breast cancer? Jens Huober Where do we stand at the moment with TNBC and HER2+ advanced breast cancer? Cornelia Leo...
by PEAK Medicals | 19 April 2023
HER2 in Breast, Lung & GI Cancers Welcome & general introduction into HER2 testing Sabina Berezowska HER2 as a biomarker in breast cancer Zsuzsanna Varga Treatment considerations for HER2-positive GI-cancers Florian Lordick Clinical implications of HER2 in lung...
by PEAK Medicals | 2 November 2022
BRCA Mutated Tumors Welcome & introduction by host Berna Özdemir BRCA as a biomarker: the who, when and how in BRCA testing Elena Guerini-Rocco Treatment considerations for BRCA mut. ovarian cancer Isabelle Ray-Coquard BRCA in prostate cancer: prognostic and...
